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Abstract
Introduction
Clinical trials conducted in sub-Saharan Africa have helped to address the prevalent health
challenges. The knowledge about how communities perceive clinical trials is however only
now evolving. This study was conducted among parents whose children participated in past
clinical trials in northern Ghana to assess their knowledge and perceptions of clinical trials
and the use of biomedical samples.
Method
This was a qualitative study based on eighty in-depth interviews with parents. The partici-
pants were randomly selected from among parents whose children were enrolled in a clini-
cal trial conducted in the Kassena-Nankana districts between 2000 and 2003. The
interviews were transcribed and coded into emergent themes using Nvivo 9 software. The
thematic analysis framework was used to analyze the data.
Results
Study participants reported that clinical trials were carried out to determine the efficacy of
drugs and to make sure that these drugs were suitable for human beings to use. The con-
duct of clinical trials was perceived to have helped to reduce the occurrence of diseases
such as malaria, cerebrospinal meningitis and diarrhea. Quality of care was reported to be
better in clinical trials than in the routine care. Parents indicated that participation in clinical
trials positively influenced their health-seeking behavior. Apprehensions about blood draw
and the use to which samples were put were expressed, with suspicion by a few participants
that researchers sold blood samples. The issue of blood draw was most contentious.
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Conclusion
Parents perception about the conduct of clinical trials in the study districts is generally positive.
However, misconceptions made about the use of blood samples in this studymust be taken
seriously and strategies found to improve transparency and greater community acceptability.
Introduction
Randomized clinical trials (RCTs) are an important part of the process of evaluating the efficacy
of new clinical interventions. Information from clinical trials help patients, clinicians, policy-mak-
ers and funding agencies to make informed clinical and health policy decisions [1, 2]. Clinical tri-
als conducted in sub-Saharan Africa during the last decade have helped to address priority health
problems such as malaria, tuberculosis, HIV and other neglected diseases in the region [3].
Reports on how clinical trials have influence the communities in which they are conducted
is mixed. There is emerging concern that the impact of clinical trials on communities needs to
be more rigorously evaluated [4]. In many places, there is the perception that the conduct of
clinical trials either directly or indirectly impacted on the quality of routine health services [5,
6]. The conduct of clinical trials has also been reported to contribute to a mal-distribution of
critically-needed health personnel, and provision of laboratory and other facilities in rural
communities [5, 7]. Evidence exist that there is lack of trust by community members on the
conduct of clinical trials [8]. Some community members put negative connotations on clinical
trials as experiments. This is reported to discourage participation [9].
There is little evidence for assessing the impact of clinical trials activities on communities
where these trials take place especially people who are recruited into these trials. Clinical trials
in resource-poor settings could negatively impact the quality of health care, by diverting
resources from routine clinical activities, by inducing “local-brain-drain” among the best quali-
fied health staff and also the issues of discrimination among enrolled as against non-enrolled
patients [9]. They may also have a negative impact on the relationships between the health
facilities and the community due to a lack of knowledge of local culture and customs by trial
researchers [10]. There is very little information on knowledge and perception of people on the
conduct of clinical trials. Conversely, the presence of clinical trials and associated rumors
regarding their “experimental” nature can adversely affect the acceptability and the full
involvement of community members in the conduct of these trial studies [9]. The misconcep-
tion on the use of blood samples during trial studies can have negative effect on the conduct of
these trials [11, 12]. With the increase in the number of clinical trials conducted in Sub-Saharan
Africa has come the need to examine these challenges more closely.
Vitamin A supplementation trial was the first clinical trial carried out by the Navrongo
Health Research Centre in the study districts. This trial assessed the impact on childhood mor-
bidity and mortality in northern Ghana [13]. A number of other clinical trials have been con-
ducted in the district since then. This study was conducted among parents whose children
participated in past clinical trials in northern Ghana to assess their knowledge and perceptions
of the conduct of clinical trials and the use of biomedical samples.
Methodology
Ethical Considerations
Ethical approval for the study was received from the Navrongo Health Research Centre ethics
committee (approval number NHRCIRB146). Written informed consent was obtained from
each participant prior to being interviewed. The moderators of the interviews read and
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translated the consent forms into the local language preferred by the participants. All partici-
pants were informed about the purpose and procedure of the study, their right to refuse or
withdraw from the study and the confidentiality of the information collected.
Study Site
The study was conducted in the Kassena-Nankana East andWest Districts (KNEWDs) by the
Navrongo Health Research Centre (NHRC). The districts share borders with Burkina Faso in the
north and covers an area of about 1675 km2. The districts have a combined population approxi-
mately 152,000 that is covered within the Navrongo Health Demographic Surveillance System
(NHDSS) [14]. The centre was established in 1989 with the main aim of conducting high quality
demographic and health research to inform policy. The centre has over the years conducted many
community-based researches in the two Kassena-Nankana districts. The districts have two distinct
seasons, a wet season that runs fromMay to September and a long dry season from October to
April with hardly any rains. The main languages spoken in the two districts are Kasem and Nan-
kani. The districts are predominantly rural with subsistence farming as the mainstay by the people.
The two districts have five health centers, two clinics, and 27 functional Community-based
Health Planning and Services (CHPS) compounds located in various villages with resident
Community Health Officers (CHOs) who offer doorstep reproductive health care services and
also treat minor health conditions [15, 16]. The main referral hospital (War Memorial Hospi-
tal) is located at the capital (Navrongo Town) of the KNED. There are two pharmacy shops
and over 50 drug and chemical shops located in various parts of the districts.
Sampling of respondents
The participants in this study were randomly selected from among parents whose children
were enrolled in a clinical trial conducted in the districts between 2000 and 2003
(ISRCTN46343627). The trial was conducted to assess the efficacy of using rectal artesunate as
pre-referral medication [17]. A little over 2000 children were recruited into the study. Using
the database of the list of participants in the trial, we used simple random sampling to select
120 parents for the interviews. This sampling technique was used to select participants in this
study because there existed a database of the parents of children enrolled in the rectal artesu-
nate trial. This approach was also sought to minimize subjective views expressed since some of
the parents were known to the research staff and could be influenced into giving opinions
based on their familiarity with the staff.
Since this trial ended in 2003 and a number of other trials have taken place in the district
that targeted children in the same age band, it is conceivable that the participants sampled in
this study may have had experience from other trials. We therefore anticipated that their views
on clinical trials as expressed in this study could not be solely attributed to their experience
during the index trial.
Data collection procedure
The In-depth interviews were conducted by university graduates who had field experience in
the conduct of qualitative research in the study area. Potential respondents in this study were
contacted and consented. Arrangements were made with participants on a convenient date,
place and time for the interviews to be conducted within the community. Each interview took
between 40 to 50 minutes. Depending on the expressed preference of the respondents, inter-
views were conducted in Kassem, Nankani or English. A total of 80 parents whose children
were recruited into the artesunate trial and possibly other clinical trials were interviewed. All of
them consented to be part of the study.
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Data Processing and Analysis
We utilized the principle of saturation for data collection in this study. Data saturation was
reached where no new or additional information is being found from the interviews [18]. Data
collection, management and analysis were done concurrently. All interviews were audio-
recorded and later transcribed verbatim after repeatedly listening to the recordings. The tran-
scripts were then uploaded onto QSR Nvivo 9 software to facilitate data management and cod-
ing [19]. To ensure a fair interpretation of the data, the transcripts were initially coded by two
researchers independently. Guided by the objectives of the study, the coding process involved a
critical review (line-by-line) of each transcript to identify emerging themes from the data. The
two coders then met to compare their independently-identified themes. They revolved diver-
gence by re-reading the relevant sections of the transcripts together, and agreed on the best fit
interpretation of the data. The major and sub-themes are discussed below, supported by rele-
vant quotes from the transcripts.
Results
Background Information of Respondents
In all, 80 parents were interviewed in this study. The ages of the parents were grouped into
three categories (24–34, 35–44 and 45–54 years). Most of them (forty two), were between 35–
44 years, twenty-three were 45–54 years while fifteen of the parents were between 24–34 years.
Most of them (seventy-five) were females while only five were males. The majority (forty-one)
of them never had formal education. Only eight had at least secondary/tertiary education while
thirty-one went up to primary/Junior high level. In terms of their occupation, thirty-nine of
them were subsistence farmers, twenty-seven were traders, nine were civil/public servants and
five of them were housewife/unemployed.
Knowledge and Perceptions on the Conduct of Clinical Trials
Most of the parents reported that researchers needed to conduct clinical trial studies to test the
drugs in order to be sure that the drugs were safe. Such trial studies needed to be carried out to
determine the efficacy of these drugs and to come out with new knowledge on whether the
drugs were suitable for human beings to use before they could be made available to a large
number of people. They said this was to help prevent the harm that these drugs could cause to
people if they were made available without testing. This was typically put as follows:
“They have to do a study to find out about the potency of the drug whether it can cure people
diseases or not. They cannot just start giving it to people without first testing it, people may
die. That is why they have to do a study to see whether it is good before they can give it to
many people to use” (IDI- 37 year old Mother)
Study respondents were of the view that even traditional medicines are usually tested on few
selected people before it is used to treat many people. They concluded that it was normal for
researchers to test modern drugs before allowing many people to use them.
“. . .even in the local way if you find a new herb for treating a disease, you have to try it on
yourself first or you select some people and test to know whether this herb is good or not. If
you know that the herb is good because you have used it to treat someone and it works, I then
take it (the herb) outside and safe the lives of those who are suffering from similar diseases”
(IDI-52 year old mother).
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Drawing and Use of Biomedical Samples (Blood, Urine, Saliva and
Stool)
Most of the respondents held the view that it was necessary for researchers to draw blood sam-
ples from trials participants because this enabled the researches know the exact disease or germ
present in the blood. This they said helped researchers to treat study participants appropriately.
Parents were of the view that it was not for fun that they had to take other samples such as
urine, saliva and stool because some diseases might not be found in the blood but rather in
saliva, stool or urine.
“There is no problem with taking of blood samples. . . because when they do the test, they will
be able to know the kind of diseases that the person has before they give the person treatment
and so for that one I don’t see it to be a problem at all” (IDI-35 year old Mother).
“[Laughter], the reason is that there are certain diseases that are in the person’s urine while
other diseases are in the blood and so when they take these samples and the disease is in the
blood they will know, if it is in the urine they will know or if it is in the stool they will know
and I think it is good for them to take those things and test” (IDI-41 year old Mother).
Perceived Benefits of Clinical Trials
Disease Reduction
Mosts of the parents reported that in the past, there used to be many “strange diseases” such as
measles and convulsion that killed people especially children. According to them, they believed
it was due to the activities of research centre that most of these diseases had been “eliminated”.
They believed that the conduct of clinical trials had had the effect of reducing the incidence or
effects of these diseases.
“there used to be measles and convulsion; with the coming of NHRC workers and their activi-
ties, there is no more measles, no more convulsion, no more “zunzure” (caterpillar).When it
all started we were ignorant but now that we understand it, we have trust in you (NHRC)
and we know you are helping us (IDI with 48 year old Mother).
“There were so many diseases before NHRC came. The drugs that they have been giving to
children have helped to drive away many diseases. Look at this my child, it was measles that
has made him so, at the time he was born, there was no NHRC. NHRC has come to drive
away measles and everything. . ..I have seen that they have done very well and I praise them
for that. They have done a lot for my child. . ..My mother had nine children and measles
killed seven of them. . .. That child had measles when we were down south; the others who
were here (study districts) have not suffered from measles” (IDI-39 year old Mother).
Most parents also held the view that clinical trials had helped to reduce the occurrence of
diseases such as malaria, cerebrospinal meningitis, and diarrhea in the communities. Parents
attributed the reduction to the health education activities that health workers undertook as
part of the conduct of clinical trials.
“Yeah I think it has helped to reduce certain diseases though I am not a “yezura tintonnu”
(health worker) but in my view I think malaria and other diseases have been reduced and all
is because of the health education we get from health workers when they take us to be part of
Knowledge and Perceptions about Clinical Trials and the Use of Samples
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these studies. Their work is good, they are really helping us a lot especially our children” (IDI-
44 year old Mother).
Quality of Medical Care
Majority of the parents in this study perceived the better quality of care offered clinical trial
participants to bethe main reason why clinical trials were acceptable to them. A 41 year old
mother whose child was recruited into clinical trial had this to say:
“My child had good health because when the child took part in that study (rectal artesunate
trial), he has never had that type of sickness since then so because of that I have seen that it is
beneficial to me, yes the drug is good” (IDI- 41 year old Mother).
They perceived that quality of care was better in the clinical trial than in the routine care.
They mentioned that trial participants were given better attention by study nurses and doctors.
They were also followed-up at home by trial staff.
“When you are referred to the health facility by the NHRC people, they would take good care of
you quickly than when you go there alone for routine care. I was having a child who was part of
one year study and when the child was sick, I took him there (referring to the health facility) and
when I got there the study workers took the child quickly and sent him to the doctor for treat-
ment.When the study was over and the child was not part of it again, we went to the hospital
and we had to go and join the queue before we could see the doctor unlike the first one where
they just took the child straight fromme to the doctor for examination. So to me, if you are part
of a study the care is faster and better than the routine care” (IDI- 38 year oldMother).
Few of the parents were of the view that clinical trials were conducted to help the poor to
take care of their children. They added that they did not pay for their hospital bills when they
were recruited into these trials and this helped them to be able to take care of the other needs of
their children.
Impact of Clinical Trials on Health Seeking Behavior
Parents who took part in this study reported that the participation of their children in clinical
trials had positively influenced their health seeking behavior. They noted that clinical trials had
helped them and their family members to patronize hospital treatment. They recalled that in
years past, they depended largely on traditional medicine to cure illnesses. They said that the
conduct of trial studies had improved their knowledge on the benefits of seeking early treat-
ment at the health facility. They said that health facilities have the capacity to administer infu-
sions (blood and drips) to patients when required as compared to traditional treatment. A 47
year old mother shared her view this way on the issue:
“We used to patronize herbal treatment but because of our involvement in these studies, we
now know that if you fall sick, the first place to go is the health facility because the herbalist
may treat you but cannot do blood transfusion if the need arises. I am extremely happy that it
has helped me. They said if someone is sick, I should do well to take the person to hospital and
I have seen the benefits in doing that. NHRC has shown us the way because in the past if
someone was sick, we used not to take the person to the hospital but rather apply various
kinds of herbs on the body but now hospital first before”. . .(IDI with 47 year old Mother)
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Impact of Clinical Trial on Patient Referrals
Almost all the parents who took part in this study reported that the conduct of clinical trials had
improved on patient referral from the community level to the health facility because of availability
of transportation. They said that community-based staff of clinical trials used their motorbikes or
vehicles to transport patients with severe health conditions to the health facilities. Some of them
particularly mentioned the “Bajer” (tricycle) that was used in the rectal artesunate trial.
“Yes for that one when you people were working with us if only they call your people, they
would come and pick the person to the hospital either with a car or motor. That study that my
child was part of, they had this small car with “three legs” (three-wheel) that they were using
to carry the people to the health facility and I wished that type of small car was still there to
help people” (IDI-40 year old Mother).
Perceived Disadvantages of Clinical Trials
Perceptions on Exposure to Risks during Clinical Trials
Few of the parents however, highlighted some issues they did not like when their children took
part in these trials. They held the view that taking of blood samples from sick children was
painful and made the children to cry. They also expressed concern about how staff engaged in
clinical trials still went ahead to draw blood samples from children who already looked weak
and pale. A 39 year old mother had this to say on the issue:
Q:What problems or risks did your child get in the trial study you took part?
R: You always think that, “oh, this child is sick and yet they are taking his/her blood; his blood
is not much” but what can you do?. . ..(IDI-39 year old Mother).
Adverse effects were also reported by some of the parents. They opined concern about possi-
ble suffer adverse effects of trial drugs and the possibility it could cause disabilities. One parent
explained that her child had developed speech problems (stammering) a situation she believed
might have been as a result of enrolling the child in a clinical trial.
“Yes but what I have to say small is that my child who was part of the study, at the moment
the child cannot talk well (child stammering) and I don’t know why whether it is because the
child was given that drug or what?” (IDI-34 year old Mother)
Another parent was of the opinion that individuals involved in clinical trials suffered psy-
chological trauma as researchers reveal findings of studies which hitherto were unknown to
them and other community members.
“hmm we have advantages and disadvantages. . .this can also bring about panic to the people
around when they get to know that there is a particular disease or sickness that is within the
area mean while they people don’t know and that can make them feel bad because they did
not know that there is something like that within them” (IDI- with 46 year old father).
One father expressed the view that clinical trial participants were being used as guinea pigs.
He explained that these trials drugs could work well for some participants and not so well
other participants.
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“Yes there are risks because you test and the results are positive, you test and the results are
negative and so there is a risk there but you cannot actually succeed in life without taking
risks. Let’s say that this drug is taken orally, it can burn your triode when you are taking it
and the intestines can be destroyed and you can be sorry and these are some of the risks
involved. So my view about these trials is that people are being used as guinea pigs because
sometimes it may come out well for some participants and another time things may not work
well for other participants”(IDI with 48 year old father)
Perceptions on Drawing and the Use of Samples
Few parents were not happy about the taking of samples from their children. They appeared to
express a sense of helplessness as they perceived they had no choice other than to allow
researchers to take such samples from their children. They added that this was because the chil-
dren were sick and needed help, and they had consented to the procedures of trials. Some
parents feared that blood taken from their children could get tested for HIV. These were
expressed with a mixed sense of mistrust and anxiety. Further to the issue of mistrust was the
suspicious expressed by few participants that blood samples were sold to local and interna-
tional partners. A number of parents were particularly worried that researchers were not com-
ing back to tell them what they found in the samples they took from their children.
R: The blood sample I must say that though you normally take it as part of these studies but at
the end of the day we don’t normally know what you use the blood for whether you take it and
sell or not we don’t know.We think that you normally use it for other things rather than what
you said you were going to take it for and that had been the problem with the blood taking.
Q: Is that the way people think in your community?
R: Yes even me, and that is why certain times I may not want people to take my blood samples
because you may go and use it to test for HIV. So sometimes we are not happy about it (IDI-
48 year old father).
Discussion
In this study we have found that parents’ perception of clinical trials is mixed and based on rea-
sonably-founded rationalization of the actions of the researchers and the research centre.
There is impressive appreciation of the role of clinical trials in developing new and safety medi-
cines. This is possibly a result of the fact that the population in the study area was familiar with
the conduct of clinical trials and must have heard the basis of the conduct of clinical trials. The
findings are however consistent with the findings of similar studies in both high and low
income countries [5, 11, 12].
While those who exhibited knowledge of clinical trials did so impressively, few of them were
not able to mention the reasons for the conduct of clinical trials. This could be attributed to
poor sensitization and education prior to trial implementation. It might also be blamed on
poor consenting before parents take a decision to allow their children to participate in these
new drug trials. It might also be as a result of parents’ eagerness to get medical attention for
their sick children which compels them to accept participation of their children without know-
ing why these trial studies are conducted. The finding in this regard is consistent with the find-
ings from similar studies in other parts of Sub-Saharan Africa [8, 10, 20].
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The study has shown how overall collateral benefit accrues for the conduct of clinical trials
when the work of a research centre is seen to result in reduction in morbidity and mortality.
Parents in this study perceived a link between the work of the research centre and decline in
the burden of disease in the districts. The perception of parents in this regard coincides with
the findings of epidemiological studies in the districts that have demonstrated substantial
reduction in child and adult mortalities. [21, 22]. While acknowledging these as objectively ver-
ifiable, it needed to be recognized that community members tended to exaggerate the position.
For instance, while the research centre has not undertaken any major work in the control of
measles, measles was among diseases often mentioned by respondents. Ghana has overall expe-
rienced substantial reduction in the incidence of immunizable diseases.
The study revealed that people who take part in trial studies have access to quality health
care. They also have access to drugs, free and prompt access to medical care. These findings
coincide with those in other studies [5, 23]. It is clear that parents placed a high premium on
the quality of care their children received when they were recruited into these trials and this
influenced their favorable perception of clinical trials. The study has thus demonstrated the
irony that unavoidable improvement in the quality of care offered clinical trial participants
leads to a preference over routine care. This well-founded basis, on the other hand potentially
undermines the integrity of the informed consent procedure. There is some degree of compul-
sion to enroll in clinical trials that is imposed by systemic failings of the routine health delivery
system.
The health-seeking behavior of trial participants was also reported to have improved tre-
mendously as a result of the conduct of clinical trials and other activities of the research centre.
Of particular mentioned was the community-based health planning and services concept
where nurses are stationed at the community level to offer basic health care services including
health education to people. The CHPS concept was carried out by the NHRC which is now a
policy in Ghana [15, 16]. Because of the nearness of these health facilities to the people couple
with the health education and the activities of clinical trials, people are usually encouraged to
visit the health facility for health care services. Earlier studies reported that trials participants
had access to health education and scientific knowledge as compared to non-trials participants
[9, 10]. It is not therefore surprising for parents to associate the availability of health facilities
and improved medical care with their participation in clinical trials.
Clinical trial participants in this setting are also exposed to some disadvantages or risks for
their involvement in clinical trials. A particular concern is the crying of children during sam-
ples taking and possible side effects such as burning of triode and possible death. It has been
reported that uncertainty in the efficacy of new drugs and the side effects new drugs may have
on the liver and kidney are source of concern to trial participants [8, 9, 10]. It is therefore
important that clinical trials in this and similar settings ensure full disclosure of information
including anticipated risks, benefits and trial procedures [9]. Most of the parents who took part
in this study however, expressed strong belief in the efficacy of study drugs used in this setting.
Apparently, this trust is based on long history of good research conducted by the NHRC over
the years in the communities.
The drawing of blood, processing and analysis are inevitable accompaniment of clinical tri-
als. Studies have shown that communities or study participants may hold views that are incon-
sistent with the motives and principles of the conduct of clinical trials [11]. Misconceptions’
regarding the use of samples affected recruitment and retention of study participants in clinical
trials [11, 12]. Our findings revealed varied opinions on the drawing and use of blood samples.
The dominant opinion by parents that samples are drawn to establish the causes of illness for
appropriate treatment might be explained by participant’s exposure to research trials. Thus,
future clinical research operations in this setting will most likely attract community support
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and participation. However, attention should be paid to isolated misconceptions regarding the
taking of blood samples during clinical trial studies for sale or for testing HIV. These views
were apparently fueled by a perceived weak community engagement and poor communication
on findings made on blood samples. This therefore raises questions on the actual use of blood
samples by trial participants.
Traditionally, the aims and objectives, study design and procedures, participant’s rights and
procedures are usually spelt out in participant’s informed consent forms for completion. Simi-
larly, durbars are usually organized (community meeting of chiefs and people) where aggregate
results from trials are disseminated. Poor organization and low community patronage of these
meetings would imply only few community members receive information on the results of
clinical trials. It is also possible that research trials may have failed to conduct disseminations
on findings of their studies. Therefore, strengthening community involvement prior to trials
implementation and effective community based disseminations would thus be key in dispelling
negative perceptions on the use of samples taking during clinical trials. This will help in sus-
taining trials participants and other community members’ interest and support in the conduct
of clinical trials [24].
Conclusion
Generally, there is positive perception on the conduct of clinical trials in the Kassena-Nankana
districts. It is therefore unlikely that the community members will reject trials undertaken
under the aegis of the research centre in the study area. The reported negative attributes cannot
however be ignored either. Misconceptions abound about the use to which blood samples are
put and the unknown effects of new drugs must be given serious attention. The process of com-
munity engagement should be continuous and never compromised in the pursuit of an
enabling community attitude towards clinical trials in this and other districts in sub-Saharan
Africa.
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